GlassScriptPhysician profile
Aman Dhawan
NPI 1861558280
$38,611.48
in general payments reported to CMS, 2019-2025
7 companies · $14K in 2025
The $14K reported for 2025 was more than what 89% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,624 · 2020: $2,277 · 2021: $84.62 · 2022: $13K · 2023: $2,294 · 2024: $2,211 · 2025: $14K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $13K · Travel and Lodging: $3,741 · Food and Beverage: $2,156.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $12,756.25 |
| Travel and Lodging | $3,741.15 |
| Food and Beverage | $2,155.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $29,337.02 | 2019-2025 | Healicoil, Aetos Shoulder System, Accu-Pass |
| Arthrex, INC. | $6,214.28 | 2019-2024 | |
| Novus Surgical Consultants | $1,749.93 | 2023-2025 | |
| Stryker Corporation | $771.67 | 2019-2023 | Gmrs, Tritanium, Mako |
| Bioventus LLC | $233.43 | 2022 | |
| Linvatec Corporation | $169.28 | 2020 | |
| Miach Orthopaedics, INC. | $135.87 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aman Dhawan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.